Login to My NLA Account

test

Join us for our BRAND NEW! Mastering Triglyceride Science Master’s Course – a 1-day master’s level course designed to address knowledge, competence, and practice gaps in managing hypertriglyceridemia and its associated pathophysiological manifestation and to provide you with improved proficiency on the complexities of severe hypertriglyceridemia, and targets of therapy. 

The course will review the latest evidence and research on triglyceride disorders, targets of therapy, and existing and novel triglyceride-lowering therapies. Participants will be expected to improve their severe hypertriglyceridemia knowledge and competence, expand the depth of their understanding of lipid science, and help their patients make informed decisions about lipid therapies to reduce the risk of extreme complications related to severe hypertriglyceridemia.

2024 Course Dates:

TARGET AUDIENCE

The Mastering Triglyceride Science: An In-Depth Master’s Course is designed for an audience of lipidologists and lipid specialists, researchers, and other specialists with advanced knowledge and experience in preventive cardiology and/or lipid science.

This course will be held in conjunction with the NLA’s 2024 Scientific Sessions and 2024 Fall Clinical Lipid Update as a pre-conference activity.

At the conclusion of this activity, participants should be able to:

  • Discuss strategies for the management of patients with lipid disorders.
  • Recognize the prevalence of triglyceride-rich remnant lipoproteins in ASCVD.
  • Discuss treatment options for hypertriglyceridemia, both for primary and secondary prevention of cardiovascular events in patients with ASCVD.
  • Outline appropriate therapy options for high CVD risk patients with elevated triglyceride levels.
  • Identify the clinical and genetic attributes, available diagnostic tools, and screening practices to aid the identification of individuals with chylomicronemia syndrome.
  • Explain the role of genetic testing in the identification of familial chylomicronemia syndrome (FCS) and multifactorial chylomicronemia (MCM).
  • Outline appropriate therapy options for patients with chylomicronemia syndrome and multifactorial chylomicronemia.
  • Discuss strategies to improve the knowledge, skills, or performance of the healthcare team.

Coming Soon!

Zahid Ahmad, MD

Course Chair
Associate Professor of Internal Medicine
Lipid Section, Division of Endocrinology
UT Southwestern Medical Center
Dallas, TX

Venkata S. Akshintala, MD

Assistant Professor
Program Director, Medical Pancreatology and Therapeutic Endoscopy Fellowships
Johns Hopkins University School of Medicine
Baltimore, MD

Alan S. Brown, MD MHA FACC FASPC FAHA MNLA

Director, Lipid Clinic
Advocate Lutheran General Hospital
Clinical Professor of Medicine
Rosalind Franklin School of Medicine and Science
Chicago, IL

Nivedita Patni, MD

Director, Pediatric Endocrinology Fellowship
Assistant Professor of Pediatrics
Division of Pediatric Endocrinology
UT Southwestern Medical Center
Dallas, TX

Abhimanyu Garg, MD

Professor of Internal Medicine, Chief, Section of Nutrition and Metabolic Diseases, Division of Endocrinology
UT Southwestern Medical Center
Dallas, TX

* The live agenda will be updated throughout the planning process as new information and outcomes data is released.

Wednesday, May 29, 2024

Day 1

7:30 AM - 8:00 AM Welcome | Pre-test
8:00 AM - 9:00 AM Physiology and Disorders Associated with Triglyceride Synthesis and Secretion, Lipolysis/Clearance, and Remnant Removal Abhimanyu Garg, MD
9:00 AM - 9:20 AM Question and Answer
9:20 AM - 9:40 AM MCS Zahid Ahmad, MD, FNLA
9:40 AM - 10:00 AM FCS Nivedita Patni, MD
10:00 AM - 10:20 AM Question and Answer
10:20 AM - 10:30 AM Break
10:30 AM - 10:50 AM Lipodystrophies Abhimanyu Garg, MD
10:50 AM - 11:05 AM Question and Answer
11:05 AM - 11:45 AM Mechanism, Diagnosis, and Treatment of Hypertriglyceridemic Pancreatitis Venkata S. Akshintala, M.D. (May), Ellie Afghani, MD, MPH (September)
11:45 AM - 12:00 PM Question and Answer
12:00 PM - 12:25 PM Abstract Presentations
12:25 PM - 1:15 PM Lunch
1:15 PM - 1:45 PM Mechanism, Diagnosis, and Treatment of Increased ASCVD Risk from Remnant Lipoproteins Alan S. Brown, MD, MNLA
1:45 PM - 2:05 PM Question and Answer
2:05 PM - 2:35 PM Current and Future Pharmacologic Treatments for Hypertriglyceridemia Zahid Ahmad, MD, FNLA
2:35 PM - 2:45 PM Question and Answer
2:45 PM - 3:00 PM Break
3:00 PM - 4:00 PM Interactive Patient Cases | Roundtable Discussion | Tips & Tricks All Speakers
4:00 PM - 4:20 PM Post-Test